Latest / UK Column Radio / UK Column News Podcast 22nd November 2024
Transcript
- 0:08Speaker 1: Good afternoon. Today is Friday, the twenty second of November
- 0:13Speaker 1: twenty twenty four. Welcome to UK column News. I'm your host,
- 0:16Speaker 1: Brian Gerrish. Delighted to be joined today by Debbie Evans,
- 0:21Speaker 1: but sadly Mark Anderson will not be joining us from
- 0:24Speaker 1: the States as he's poorly today. But nevertheless we've got
- 0:28Speaker 1: a very interesting and we think exciting news for you today.
- 0:33Speaker 1: We're going to be focusing on health, the fallout really
- 0:37Speaker 1: of COVID nineteen, the vaccinations lockdown policy and above all
- 0:43Speaker 1: the work of our supposed regulator, the MHRA. And we
- 0:48Speaker 1: have a particular announcement to make this is an exclusive
- 0:52Speaker 1: UK column News. We're hoping to be joined by Cheryl
- 0:57Speaker 1: Granger a little bit later in the news. Now. We'll
- 1:00Speaker 1: tell you more in due course, but I'm just going
- 1:02Speaker 1: to start off by saying, let's remind ourselves a little
- 1:06Speaker 1: bit of all the work that the UK column team did,
- 1:09Speaker 1: particularly Debbie and cheryld Grainger, in order to inform the
- 1:14Speaker 1: UK public what was really happening around the vaccination program
- 1:19Speaker 1: and in particular adverse reactions as recorded on the yellow
- 1:23Speaker 1: card system run by the MHRA. Now, this is just
- 1:28Speaker 1: a very small selection of articles and reports that UK
- 1:32Speaker 1: Column put out. There's no smoke without fire. There's Debbie's blog,
- 1:37Speaker 1: there's articles and interviews, and we just continue on through.
- 1:42Speaker 1: We even got the engagement of people like Sir Christopher Chopemp,
- 1:46Speaker 1: who was very happy to say to us that he
- 1:49Speaker 1: was very willing to learn more about the failures of
- 1:52Speaker 1: the system and how the system actually worked, because it
- 1:56Speaker 1: was clear when we talked to him in private at least,
- 1:58Speaker 1: that he he had little understanding in some areas. And
- 2:04Speaker 1: of course we shouldn't blame him for that, because of
- 2:06Speaker 1: course MPs and members of the Lords were not being
- 2:10Speaker 1: properly briefed on what was happening, and so it took
- 2:14Speaker 1: the UK Column team to step up to the mark
- 2:17Speaker 1: in order to start pushing out more information. I've already
- 2:22Speaker 1: mentioned this lady's name, but let's poper on screen. Cheryl
- 2:25Speaker 1: Granger has been working with the UK Column and working
- 2:29Speaker 1: on her own in the background to tackle what we
- 2:34Speaker 1: believe is a complete failure of the MHR regulatory system
- 2:40Speaker 1: at least to try and keep the UK public safe.
- 2:43Speaker 1: So Cheryl has done a huge amount of work and
- 2:46Speaker 1: she's going to be central to today's news and We
- 2:49Speaker 1: very much hope that in the latter stages of today's
- 2:53Speaker 1: news we're going to be able to have Cheryl with
- 2:55Speaker 1: us to tell us a little bit more about what's happening.
- 3:00Speaker 1: I've so stay posted for that.
- 3:02Speaker 2: Now.
- 3:03Speaker 1: I want to also remind the audience today that all
- 3:07Speaker 1: of the data that UK Column stored onto the database.
- 3:13Speaker 1: This was government release data which has subsequently disappeared from
- 3:17Speaker 1: MHR channels at least, but you can still find it here.
- 3:21Speaker 1: If you go to www. Dot Yellowcard, dot UK column
- 3:27Speaker 1: dot org. You see the yellow opening page and if
- 3:31Speaker 1: you click on view Adverse Reaction Data, that will take
- 3:36Speaker 1: you into the database itself and you will see something
- 3:40Speaker 1: like this where you can actually see the actual government
- 3:45Speaker 1: figures on the respective vaccine manufacturers. You can see the reports,
- 3:50Speaker 1: the reactions and the fatalities. But most importantly, you can
- 3:55Speaker 1: enter into the database and search for particular things that
- 3:59Speaker 1: you are particularly interested in. So that hasn't that material
- 4:04Speaker 1: hasn't gone away, and that is the address for you
- 4:08Speaker 1: to access it. Now, Debbie, let me welcome you to
- 4:11Speaker 1: the UK Column. It seems we have the more mature
- 4:15Speaker 1: team on today, so we'll do our best. And what
- 4:19Speaker 1: have you got and what can you tell us about
- 4:22Speaker 1: this special event around MHR and MHR data.
- 4:29Speaker 3: Well, yes, good afternoon everyone. Lovely to be here as always,
- 4:32Speaker 3: and as you know, the MHR have been well, we've
- 4:36Speaker 3: had them scrutinizing them for since the beginning of the
- 4:40Speaker 3: lock up, and I have to say that Cheryl Granger
- 4:44Speaker 3: has been an absolute store. She's been incredible. You have
- 4:47Speaker 3: no idea what she's been doing behind the scenes. And
- 4:50Speaker 3: this is all with regards to pregnancy monitoring data. So
- 4:54Speaker 3: this is going to be It's groundbreaking, It's simply groundbreaking.
- 4:57Speaker 3: So please stay tuned to the end of the news
- 5:00Speaker 3: and those of you who are vaccine injured, vaccine bereaved,
- 5:04Speaker 3: I'm hoping that this news will be particularly important for
- 5:08Speaker 3: you as well. But before we get on to more
- 5:10Speaker 3: about the MHRA, because there will be more about the MHRA,
- 5:14Speaker 3: let's talk about Antimicrobial Resistance Awareness Week, because that's what
- 5:19Speaker 3: it is, and of course Charles Mallett was talking about
- 5:22Speaker 3: it on Wednesday with regards to one health and animals.
- 5:26Speaker 3: But I want to focus a little bit on what's
- 5:28Speaker 3: been going on on the human side, and I've got
- 5:31Speaker 3: a video to show you, and I do apologize in advance.
- 5:35Speaker 3: Some of the children that they have used are actually
- 5:39Speaker 3: probably too young to properly for us to properly understand them.
- 5:43Speaker 3: They are literally that young. And I have to say
- 5:45Speaker 3: that vaccines and antimicrobial resistance are inextricably linked. So let's
- 5:52Speaker 3: have a look at this little piece of video.
- 6:09Speaker 4: At biological One. Thoughts were to look at other work.
- 6:15Speaker 4: But we don't use antoppoticly Wisely, you can lead to
- 6:18Speaker 4: anti microbial resistance and making party treat Ninety five percent
- 6:22Speaker 4: of people who think they have a penicillin allergy aren't
- 6:28Speaker 4: actually allergic. Corse, allergies lead to patiently steeping.
- 6:34Speaker 2: That's effective treatment.
- 6:36Speaker 4: I can stay in the hospital longer.
- 6:38Speaker 2: Taking diagnostic examples before starting antibiotics means that we can
- 6:42Speaker 2: start mat and then focus when treating patients.
- 6:45Speaker 4: Let me, switching to oral antibiotics can save the NHS
- 6:51Speaker 4: millions and means patients can.
- 6:54Speaker 3: Go home sooner.
- 6:56Speaker 2: Invactual prevention is important. Who vaccines tell those people certain infections.
- 7:02Speaker 2: I have had my vaccine to PreTect me and my friends.
- 7:09Speaker 2: Anti microbial resistant is everyone's from.
- 7:16Speaker 4: I want to gad I'm kibiotic when I go on
- 7:21Speaker 4: so a'mtibiotic cardian, Are you.
- 7:27Speaker 1: Wi? If I may? If I could just come back
- 7:29Speaker 1: in there, because I'm seeing that video for the first
- 7:31Speaker 1: time along with UK column view as the audience today,
- 7:35Speaker 1: I find this utterly disgusting that young children are being
- 7:40Speaker 1: used to push across a message which they cannot possibly understand.
- 7:45Speaker 1: I would go so far as to say this that
- 7:47Speaker 1: is actually abuse of children. And I wonder what the
- 7:50Speaker 1: children's reaction would be if they were showing people in
- 7:53Speaker 1: wheelchairs as a result of vaccine damage. I think this
- 7:58Speaker 1: is utterly discreet. Whoever produces this.
- 8:01Speaker 3: Video, yeah, it was Lancashire NHS Trust and there were
- 8:07Speaker 3: the Internet is abounding with antimicrobia resistance and I chose
- 8:12Speaker 3: that one Brian specifically for that reason because I felt
- 8:15Speaker 3: it was so shocking. Those children cannot possibly know what
- 8:18Speaker 3: they're saying, They cannot possibly understand what they're saying. But
- 8:23Speaker 3: who else is hearing them? And we have to go
- 8:26Speaker 3: back really to Dame Sally Davis and act now that's
- 8:32Speaker 3: what she wants to do. Act and play, Act and play.
- 8:35Speaker 3: This is all the whole message of antimicrobia resistance, and
- 8:39Speaker 3: Dame Sally Davis well she's a resistance fighter, don't you know,
- 8:44Speaker 3: And she calls herself a resistance fighter. But let's just
- 8:48Speaker 3: remind ourselves of who she actually is, because she was
- 8:51Speaker 3: a previous Chief Medical Officer and she is now the
- 8:54Speaker 3: UK Special Envoy for Antimicrobia resistance, and Antimicrobia resistance is
- 8:59Speaker 3: her baby. And I don't forget Mike's often talking about
- 9:02Speaker 3: her because she's the lady that recommended using baby wipes
- 9:05Speaker 3: when wiping your hands. If you should touch novichok, I'll
- 9:08Speaker 3: say no more. But here are few of her tweets
- 9:11Speaker 3: because she's Superwoman. So this is the first tweet where
- 9:15Speaker 3: she says that superbugs are on the rampage. And note
- 9:19Speaker 3: please that this is in a hospital environment, and she
- 9:22Speaker 3: very much looks like the cartoon character. And she says
- 9:25Speaker 3: tests show bacterial infections and she's got superpower. And if
- 9:29Speaker 3: we go to the next slide, we've got part two
- 9:32Speaker 3: because her superpowers now in the local hospital. Please note
- 9:36Speaker 3: that these are hospitals she's showing, but they're waning. So
- 9:40Speaker 3: what should she do? Well In the next slide, you'll
- 9:43Speaker 3: see that she's flying off to the United Nations because
- 9:47Speaker 3: together she and the United Nations can beat AMR. So
- 9:51Speaker 3: I decided to fly off to the United Nations as well.
- 9:54Speaker 3: And who did I see there but Ted Ross. This
- 9:56Speaker 3: was just last week. This was in Jedda where they
- 9:59Speaker 3: had a heart level ministerial meeting talking about antimicrobial resistance
- 10:04Speaker 3: and what did he have to say? So what he
- 10:06Speaker 3: had to say was that he felt he said that
- 10:09Speaker 3: AMR was killing one point three million people a year.
- 10:12Speaker 3: We have to act now. So as well as Dame
- 10:15Speaker 3: Sally Davis, I'm going to introduce you to Professor Doctor
- 10:19Speaker 3: Professor Diane Ashiru. She's the lead pharmacist for antimicrobial resistance
- 10:25Speaker 3: in the UK. She's a Professor of Public Health. And
- 10:28Speaker 3: here she is showing off her cupcakes for Antibiotic and
- 10:32Speaker 3: Antimicrobial Awareness Week, her aware cakes and if you zoom
- 10:36Speaker 3: into that at some point you'll see lots of bugs
- 10:38Speaker 3: and lots of lovely things on her cakes. But it's
- 10:41Speaker 3: a massive, massive issue, and I just want to show
- 10:43Speaker 3: you a selection of what's been circulating around social media,
- 10:48Speaker 3: so we'll go through them quite quickly. So here we've
- 10:51Speaker 3: got the HSC memes. Antibiotics we're discovered one hundred years ago.
- 10:56Speaker 3: We need to keep them effective for another hundred years.
- 10:58Speaker 3: We've got a meme there from the World Health Organization
- 11:01Speaker 3: antibiotics are life savers, and we can go on and
- 11:04Speaker 3: see that on Twitter or x. The UKHSA have gone blue.
- 11:10Speaker 3: This is the Qnard and Royal Livera buildings. It's flooded
- 11:13Speaker 3: in blue neon light because apparently that's the color of AMR.
- 11:17Speaker 3: And then we've got the NHS moving forward, the NHS
- 11:21Speaker 3: Antimicrobial Stewardship, and we see mention of the sustainable goals.
- 11:27Speaker 3: If you just flip through these slides fairly quickly, Brian,
- 11:30Speaker 3: I just literally want to show what a massive, massive
- 11:33Speaker 3: deal this. I mean, you can see the sustainable goals
- 11:35Speaker 3: up there. If we go on to the next one,
- 11:37Speaker 3: We've got the National Institute of Health keeping antibiotics working
- 11:41Speaker 3: the UKHSA Targeting Programming GPS to learn about antimicrobial resistance.
- 11:48Speaker 3: We've got the Royal Orthopedic Hospital, the NIHR Antibiotic Guardian,
- 11:54Speaker 3: and then we can turn the UKHSA blue again. Three
- 11:57Speaker 3: steps to take only take when proscrire well. You know what,
- 12:00Speaker 3: in the UK United Kingdom, we can only get antibiotics
- 12:03Speaker 3: if they're on prescription, So I don't know how they
- 12:06Speaker 3: think we're taking them when we're not prescribed them. But anyway,
- 12:09Speaker 3: moving on, we can see that we've got the World
- 12:11Speaker 3: Health Organization advertising antibiotic resistance and West Yorkshire Health and
- 12:16Speaker 3: Care Partnership and then we go on again. So this one,
- 12:20Speaker 3: thank you Kenny for sending me this tweet from the UKHSA.
- 12:23Speaker 3: Do go and read this blog how science and snake
- 12:26Speaker 3: Bites is taking on superbugs. Thank you Kenny for that.
- 12:30Speaker 3: But what's the alternative? So according to Antibiotic Research UK,
- 12:35Speaker 3: we're looking at mRNA. Of course, the mRNA platform, the
- 12:38Speaker 3: one platform that we really should never ever have used.
- 12:41Speaker 3: And if we go on to Medical Press we can
- 12:44Speaker 3: see that they're also investigating mRNA antibiotics. And there's even more.
- 12:49Speaker 3: Let's go to Science Direct who are talking about mRNA
- 12:53Speaker 3: vaccine platforms to prevent bacterial infections. But what of now?
- 12:58Speaker 3: What of today? What are the NHS says today? Well,
- 13:00Speaker 3: they're saying, watch out, folks, we've got a highly contagious
- 13:04Speaker 3: superbug that's hitting the UK and bingo, it's EcoLine. We've
- 13:09Speaker 3: talked so many times about EcoLine and here we go again,
- 13:12Speaker 3: and this is causing apparently sixty five percent of antibiotic
- 13:16Speaker 3: resistance infections over the last five years. So well, we
- 13:20Speaker 3: need to look at the indicators. So I went to
- 13:22Speaker 3: the Department of Health and Social Care and I looked
- 13:25Speaker 3: at the antimicrobial Resistance Local Indicators which were produced by
- 13:29Speaker 3: the UKAHSA. And on the next slide you can see
- 13:32Speaker 3: that top of the poops is seediff, which is a bacteria.
- 13:38Speaker 3: It affects the bow mainly after antibiotics. And then we've
- 13:42Speaker 3: got ecolin, which is also antibiotic resistance. And we've also
- 13:46Speaker 3: got clubs yeller and that's a bug that lives in
- 13:49Speaker 3: the guts, but if it gets to the lungs, it
- 13:51Speaker 3: causes huge problems. And these are all hospital acquired infections.
- 13:55Speaker 3: I have to highlight that hospital acquired, so if we're
- 13:58Speaker 3: going to see hospitals closed in the future, you'll know why.
- 14:01Speaker 3: And I've found this company, Glockx Therapeutics. They've been given
- 14:05Speaker 3: a massive one million PACE grant to accelerate development of
- 14:09Speaker 3: precision antibiotics. What in pneumonia, Ecoli, clubsila, high value, high
- 14:15Speaker 3: risk early phase drug discovery. If you want to go
- 14:18Speaker 3: and look at their website, there's a screenshot of it here,
- 14:21Speaker 3: please go and have a look. They're huge. And the CEO,
- 14:24Speaker 3: James Clark, he's got great history glaxosmith Klein and Entero Biotics.
- 14:30Speaker 3: Every time the word Entero is mentioned, please think intestines.
- 14:35Speaker 3: So lots going on on AMR, and there's going to
- 14:37Speaker 3: be lots more going on in AMR as well.
- 14:41Speaker 1: Deby, thank you very much for that. Now I'm going
- 14:44Speaker 1: to say to the audience, I'm going to do a
- 14:46Speaker 1: very short comment really on the Russian ICBM launch in Ukraine.
- 14:53Speaker 1: A lot of people talking about it. But what I
- 14:56Speaker 1: also want to emphasize is why many, well many people
- 15:00Speaker 1: are becoming very fearful of the situation and what seems
- 15:03Speaker 1: to be a creep towards World War III. We at
- 15:07Speaker 1: UK column are going to say, pay attention to the basics,
- 15:10Speaker 1: what's happening around the pharmaceutical industry and attacks on our health,
- 15:15Speaker 1: and also think about our children because the government grooming
- 15:19Speaker 1: and attacks on our children and our children minds still happening.
- 15:23Speaker 1: Let's just pop that one back on screen. This is
- 15:26Speaker 1: the male with a very emotive, if somewhat strange headline page.
- 15:32Speaker 1: Lots of videos of rockets going off, putin ups the
- 15:36Speaker 1: stakes moment. Nuclear cable, Russian long range missile strikes Ukraine.
- 15:41Speaker 1: But the key thing about this attack is that, of
- 15:43Speaker 1: course Ukraine did not carry out the attack along range
- 15:47Speaker 1: of long range missiles on Russian soil. That was done
- 15:52Speaker 1: by using NATO expertise on the ground, whether it was
- 15:57Speaker 1: US or uk possibly German. So we are fully involved
- 16:02Speaker 1: in this war now attacking Russian sovereign soil. And what
- 16:06Speaker 1: did the Russians do? They demonstrated another missile system to
- 16:11Speaker 1: which or against which the West simply has no defense.
- 16:16Speaker 1: This is a little bit of film footage that's been
- 16:19Speaker 1: circulated not only on social media, but also appearing in
- 16:23Speaker 1: the Daily Mail. And although it happens very quickly, you
- 16:26Speaker 1: will see an extraordinary site of warheads coming down through
- 16:30Speaker 1: the cloud cover and they're actually coming down in groups
- 16:33Speaker 1: of six. And this is the result of a long
- 16:36Speaker 1: range missile attack ICBM attacked by the Russians, and the
- 16:40Speaker 1: Russians are demonstrating once again that they have technology. The
- 16:45Speaker 1: West has no defense against this. Now, if we look
- 16:48Speaker 1: at how the male dealt with this, they went to
- 16:50Speaker 1: this lady Dr Ruth Diamond for comment. She's from King's College, London.
- 16:56Speaker 1: She said, this strike is no obvious military value. They
- 17:00Speaker 1: could achieve the same objectives without sacrificing an ICBM or
- 17:04Speaker 1: advanced missile. She went on to say, it looks very
- 17:08Speaker 1: much as if it's signaling to the West what Russia
- 17:10Speaker 1: could do if it chose to launch a nuclear missile.
- 17:14Speaker 1: But actually it's a sign of weakness. Just think of
- 17:17Speaker 1: what this woman is actually saying. I'm going to say
- 17:20Speaker 1: unbelievably immature, because Russia is absolutely demonstrating what it's capable
- 17:26Speaker 1: of with weapon systems against which the West has no defense.
- 17:31Speaker 1: She goes on, the Russian government knows what would happen
- 17:34Speaker 1: if they did attempt to use any kind of nuclear weapon,
- 17:37Speaker 1: so they have to resort to bluffing. Well, the Russians
- 17:41Speaker 1: have steadily shown that they're not blushing. Bluff excuse me,
- 17:44Speaker 1: They are not bluffing about anything to do with the
- 17:47Speaker 1: Ukraine War. And of course, as the advances on the
- 17:51Speaker 1: battlefield continue, they are demonstrating their winning this war, which
- 17:55Speaker 1: they're fighting not just against Ukraine but against NATO itself.
- 18:00Speaker 1: So this lady is truly unbelievable. But if you go
- 18:03Speaker 1: back in time, and this is a report she did
- 18:05Speaker 1: on YouTube watched by a few hundred people in February
- 18:10Speaker 1: twenty twenty two. She was busy saying that NATO, rather
- 18:15Speaker 1: than being weakened, is showing much more quick coherence. Well,
- 18:20Speaker 1: if we think about what we are seeing around NATO
- 18:22Speaker 1: in twenty twenty four, we're seeing absolute chaos and breakdown.
- 18:26Speaker 1: So what is the expertise of the woman that's chosen
- 18:30Speaker 1: to comment on this. Well, here she is Dr Ruth Diamond,
- 18:33Speaker 1: senior lecturer in post Soviet security. And if we get
- 18:37Speaker 1: into a background, she completed a PhD in government and
- 18:41Speaker 1: an MA in International relations. Before this, she worked in
- 18:45Speaker 1: the treasury, so she was into financial institutions. She's got
- 18:50Speaker 1: a degree in English Language and literature and an MA
- 18:53Speaker 1: in English and European Renaissance drama. I'm going to say,
- 18:58Speaker 1: in my opinion, simply not ridable. Where are the senior
- 19:02Speaker 1: military people in UK to comment on what's happening? They
- 19:06Speaker 1: seem to be absent. But I'll just bring this gentleman
- 19:09Speaker 1: on screen. This is Pedro Israel Orta. He's a former
- 19:15Speaker 1: CIA agent who I interviewed yesterday. One of the points
- 19:20Speaker 1: that he's making, as our other retired CIA operatives is
- 19:25Speaker 1: that the expertise has gone out of the intelligence services
- 19:29Speaker 1: to the extent they can't function properly. If that's happening
- 19:32Speaker 1: with CIA. Our own Alex Thompson has said this about
- 19:36Speaker 1: security within GCHQ and also the security services in UK.
- 19:42Speaker 1: We do not have the people to comment coherently and
- 19:47Speaker 1: properly on overseas matters, particularly what's happening in Ukraine with
- 19:53Speaker 1: the Russians. So I leave people to reflect on that,
- 19:56Speaker 1: but clearly the Daily Mail at least cannot find the
- 19:59Speaker 1: suit expert to comment. Debby, let's bring you back in
- 20:03Speaker 1: and we'll get back onto the subject, the key subject
- 20:06Speaker 1: for today's news, which is the MHRA. What it's up to?
- 20:11Speaker 3: Thank you, Brian. Yes, well, of course the MHRA. This
- 20:15Speaker 3: they're celebrating the sixtieth anniversary of the Yellow Cards and
- 20:19Speaker 3: it was the board meeting, and you know how much
- 20:22Speaker 3: I do love an MHRA board meeting. So here we
- 20:24Speaker 3: are the MHRA board meeting held in public Tuesday, the
- 20:28Speaker 3: nineteenth of November twenty twenty four. However, when I logged
- 20:33Speaker 3: onto the zoom link for the meeting, I found myself
- 20:37Speaker 3: in the MHRA November Board meeting held in pubic. Yes,
- 20:45Speaker 3: I really did say that it was held in pubic.
- 20:47Speaker 3: And it's very sad, isn't it? And embarrassing when the
- 20:50Speaker 3: MHRA can't even spell. So how much trust do we
- 20:53Speaker 3: have in them in public safety? Well, I've taken the
- 20:57Speaker 3: unusual step actually of showing you what Dame June said
- 21:01Speaker 3: at the board meeting yesterday. We're going to split this
- 21:05Speaker 3: into two halves this video. The first half. I want
- 21:08Speaker 3: you to take note of what she says about antimicrobial resistance,
- 21:13Speaker 3: also the microbiome, which we've talked about, vaccines and well,
- 21:20Speaker 3: just have a listen Dame June rain MHRA board meeting.
- 21:25Speaker 5: Thank you Graham, and as colleagues will have seen, it's
- 21:27Speaker 5: quite a full report. Been a very busy time, and
- 21:30Speaker 5: I think it fully demonstrates the breadth of the agency's deliverables.
- 21:35Speaker 5: As we're here at the Science Campus today, I think
- 21:38Speaker 5: it's quite nice to focus, I think on the immense
- 21:40Speaker 5: effort for antimicrobial resistance. Antimicrobial Resistance Week is this week,
- 21:46Speaker 5: and globally forces are aligning, but here at the Science
- 21:51Speaker 5: Campus we have some real cutting edge work on bacteria,
- 21:55Speaker 5: phage and also on the microbiome, and none of that,
- 21:59Speaker 5: of course, detracts from the role on vaccines. So let's
- 22:03Speaker 5: I think, really pay a bit of tribute to the
- 22:05Speaker 5: huge efforts that Nicola is leading here in terms of
- 22:08Speaker 5: antimicrobial resistance. But that, as I say, is not to
- 22:13Speaker 5: neglect what is happening on vaccines as we prepare, ever
- 22:16Speaker 5: prepare for the coming flu in the coming year. In
- 22:20Speaker 5: terms of access to healthcare products, the earlier announcement of
- 22:24Speaker 5: a refreshed innovative licensing and access pathway has been very
- 22:28Speaker 5: much welcomed, particularly the fact that the NHS is fully
- 22:32Speaker 5: signed up to be on board with a narrower focus
- 22:36Speaker 5: on products that are truly transformative. And another important development
- 22:41Speaker 5: has been related to the work on mRNA platform technology
- 22:46Speaker 5: not just for cancer vaccines, but for personalized medicines and
- 22:49Speaker 5: guidance that will be out there for public consultation quite soon.
- 22:54Speaker 5: So the efforts to drive forward innovation really are moving
- 22:58Speaker 5: ahead quite quite strongly.
- 23:03Speaker 3: So there you have the warning that antimicrobial resistance is
- 23:06Speaker 3: going to be big on the agenda and mRNA is
- 23:09Speaker 3: going to figure in pretty much everything moving forward.
- 23:12Speaker 1: Now.
- 23:12Speaker 3: In the second part of her presentation her report, of course,
- 23:18Speaker 3: the injections the COVID nineteen vaccine are safe and effective, right,
- 23:24Speaker 3: but are all medicines safe? Dame June I don't think
- 23:27Speaker 3: they are. And Dame June here is going to put
- 23:30Speaker 3: out a very serious warning to members of the public
- 23:33Speaker 3: with regards to a GOVI. She's also going to be
- 23:37Speaker 3: talking about the very serious side effects and transformation and surveillance.
- 23:43Speaker 3: But please note there's not one word about the vaccine
- 23:46Speaker 3: injured or the bereaved. Have a listen to the second
- 23:49Speaker 3: half of Dame june reign.
- 23:52Speaker 5: Our return to Green program, on the other hand, to
- 23:55Speaker 5: make sure that performance is optimized, has reached an important
- 23:59Speaker 5: milestone with the elimination of the original backlog of established
- 24:03Speaker 5: medicines applications, and that's something I think the staff have
- 24:07Speaker 5: to be warmly commended for jobs not done though, and
- 24:12Speaker 5: return to Green remains a top priority for this year's
- 24:15Speaker 5: business plan. Perhaps I'll just then turned to our safety
- 24:19Speaker 5: work and the immense interest, almost daily interest in.
- 24:22Speaker 3: Weight loss jabs.
- 24:24Speaker 5: We recently issued a communication that reminded the public that
- 24:28Speaker 5: all medicines have risks and that there is rare ut
- 24:32Speaker 5: serious side effects associated with we Govian a ZENPIC and
- 24:36Speaker 5: to report these so important that we know about this
- 24:40Speaker 5: and if anyone turns up off label use, we can
- 24:43Speaker 5: also helpfully focus on that too. The new Medical Devices
- 24:48Speaker 5: postmarket Surveillance legislation was laid in October and that will
- 24:52Speaker 5: really help to strengthen our surveillance systems, particularly following the
- 24:56Speaker 5: Cumberlange report. So those are just some highlights, but nish
- 25:00Speaker 5: really by saying how much this all is testament to
- 25:03Speaker 5: the enormous efforts of staff, not just to drive forward
- 25:06Speaker 5: innovation and access, but to protect the public every day
- 25:11Speaker 5: of every week.
- 25:15Speaker 3: Do feel protected every day of every week by Dame
- 25:18Speaker 3: jun Rain. I'm afraid I don't. But of course we
- 25:21Speaker 3: know that the MHRA want to be top dog. They
- 25:23Speaker 3: want to be the global regulator. They've been hinting about
- 25:27Speaker 3: it for a long time, and we take ourselves to
- 25:29Speaker 3: the mhra's new international recognition procedure, so they're very much
- 25:33Speaker 3: there on the world stage looking at personalized medicine in particular.
- 25:38Speaker 3: Now the MHRA have got this secret dream of being
- 25:43Speaker 3: the global regulator. And during the board meeting, Raj Long,
- 25:47Speaker 3: who we've spoken about many times before, who has no qualifications,
- 25:51Speaker 3: who's of the stable of Bill and Melinda Gates. She's
- 25:55Speaker 3: also written the Dementia Guidance for the Department of Health
- 25:58Speaker 3: and she's also on the uk HSA board. Just please
- 26:02Speaker 3: remember she has no qualifications anyway, just out of the blue.
- 26:06Speaker 3: She dropped this in at the MHRA board meeting. June.
- 26:11Speaker 3: You've been to KOI have.
- 26:12Speaker 6: A look, Raj, did you want to say something? Thank you?
- 26:18Speaker 6: Totally unrelated to any of the topics on the agenda.
- 26:22Speaker 6: As Dune mentioned, she attended the IGMORRA meeting last week
- 26:26Speaker 6: in Brazil. So for those of you who are not family,
- 26:29Speaker 6: IGMORRA is like the world stage for global regulators. They
- 26:32Speaker 6: all come together and they you know, they agree to
- 26:35Speaker 6: Go's been very coy about this, but I think it's
- 26:39Speaker 6: important to recognize that she got the igmor Award this
- 26:43Speaker 6: year for outstanding contributions to IGMORA. This is a fantastic ecolade,
- 26:48Speaker 6: not just to June, but to the whole team in
- 26:50Speaker 6: terms of how we are seen globally. I know we
- 26:54Speaker 6: very often at the board level look at the areas
- 26:56Speaker 6: of challenges and figure out how we need to work,
- 26:59Speaker 6: but I thought it was really appropriate to take a
- 27:00Speaker 6: couple of minutes to recognize the international recognition that this
- 27:04Speaker 6: agency's had through June and her team's leadership. So I
- 27:08Speaker 6: would like to just say well done June, and congratulations
- 27:12Speaker 6: to all of you, because this is not just you know,
- 27:14Speaker 6: it's a whole agency, and congratulations and thank you ver
- 27:20Speaker 6: so congratulations on behalf of the board.
- 27:22Speaker 3: And characteristically hadn't told us, but.
- 27:26Speaker 5: I would like to stress and in thanking Rash for
- 27:28Speaker 5: your really kind words, that this reflects that the agency
- 27:31Speaker 5: has an international role and it's something we should use
- 27:35Speaker 5: so well, effectively and with pride that the excellence of
- 27:40Speaker 5: the work that we do right across the basic science,
- 27:43Speaker 5: regulatory innovation and real world evidence that is contextualizing all
- 27:48Speaker 5: our decisions that we use that for the international best
- 27:53Speaker 5: efforts for patients in the public. So I was very proud,
- 27:56Speaker 5: but as I say, it reflects everyone and that's the
- 28:00Speaker 5: absolute truth.
- 28:04Speaker 3: So do we send well done and congratulations to June.
- 28:07Speaker 3: I don't think so. However, thank you raj Long for
- 28:10Speaker 3: highlighting IKMRA, because I hadn't actually heard of it. So
- 28:12Speaker 3: who are IKMRA the International Coalition of Medicines Regulatory Authorities,
- 28:18Speaker 3: But who are they actually? Well, who they say they
- 28:20Speaker 3: are as an informal group of leaders of all the
- 28:23Speaker 3: regulatory bodies who collaborate to provide strategic directions for enhanced
- 28:28Speaker 3: common challenges like COVID, and their mission is to safeguard
- 28:32Speaker 3: public health by facilitating strategic leadership. So let's look at
- 28:35Speaker 3: the members, because it's an interesting mix of members we've
- 28:38Speaker 3: got here. So the members are including China, We've got
- 28:43Speaker 3: the European Union, India of course, who are one of
- 28:46Speaker 3: the world's largest pharmaceutical manufacturers, and we've got the UK
- 28:51Speaker 3: MHRA at the bottom. And if you look at the
- 28:53Speaker 3: associate members, it gets even more interesting. You have Israel,
- 28:57Speaker 3: who of course we all know we have a very
- 28:59Speaker 3: strong tie in many areas, but particularly pharmaceutical Russia. Are there,
- 29:05Speaker 3: Saudi Ukraine And of course we've got the who observing.
- 29:09Speaker 3: So who are Ikumra led by Will? They're led by
- 29:13Speaker 3: Irma Cook. Now she started in November twenty twenty, so
- 29:17Speaker 3: if she was doing a four year term she would
- 29:19Speaker 3: be ending that round about now, I wonder who might
- 29:22Speaker 3: be taking over. Wonder if there's anybody qualified that could
- 29:25Speaker 3: take over Ikma. I don't know, but she's also if
- 29:29Speaker 3: we could just go back to that, Ikmacook slide for
- 29:32Speaker 3: a second. Thank you. I just want to highlight that
- 29:35Speaker 3: down at the bottom there the previous IKMA chairs. You'll
- 29:39Speaker 3: see that Ian Hudson, who used to be prior to
- 29:42Speaker 3: June Rain, the CEO of the MHRA, who then went
- 29:45Speaker 3: to the Bill of me Linda Gates Foundation and who
- 29:47Speaker 3: chaired DIKMA. So will Dame June Rain be making an
- 29:51Speaker 3: appearance at IKMA. I don't know, but she's got a
- 29:53Speaker 3: special award, so who knows. Now what are they What
- 29:56Speaker 3: are they actually talking about? Most well, surprise, surprise or
- 30:00Speaker 3: not antimicrobial resistance and they're recognizing the World AMUR Awareness Week,
- 30:06Speaker 3: and if we go on, they say that eight point
- 30:09Speaker 3: two million deaths could be associated with resistant bacteria by
- 30:14Speaker 3: twenty fifty. They also go on to say that we
- 30:18Speaker 3: mustn't misuse antibiotics, and they mention in particular you can
- 30:23Speaker 3: see there one health which we've talked about so many times.
- 30:27Speaker 3: And then in the next slide they also go on
- 30:29Speaker 3: to say that global leaders can offer effective incentives new antibiotics.
- 30:35Speaker 3: They're going to incentivize people to make new antibiotics and
- 30:39Speaker 3: they're going to reward the developers. And their final message
- 30:43Speaker 3: was Act now, But what act now against this silent pandemic?
- 30:49Speaker 3: Our health depends on it. But just to finish this
- 30:52Speaker 3: little segment, one thing in the MHRA board meeting that
- 30:55Speaker 3: I did pick up and there was tons of it
- 30:56Speaker 3: and we'll talk about much more of it coming up.
- 30:59Speaker 3: But they talked about engineering biology and I didn't know
- 31:03Speaker 3: that there was such a subject. However there is and
- 31:05Speaker 3: the UK government are entrenched in it. So here you
- 31:08Speaker 3: gov dot UK National Vision for Engineering Biology. This was
- 31:14Speaker 3: Andrew Griffith, who was at the time the Minister of
- 31:16Speaker 3: State for Science, Research and Innovation. And if we look
- 31:19Speaker 3: one slide further, this is my final slide for this segment,
- 31:22Speaker 3: you can see that engineering biology is basically artificial intelligence
- 31:27Speaker 3: robotics DNA engineering mRNA where they create organisms to yield
- 31:34Speaker 3: therapies through food, chemicals and fuel. So engineering biology a
- 31:40Speaker 3: big agenda watched this space.
- 31:43Speaker 1: Okay, thank you very much, Debbie, and I'll just say
- 31:46Speaker 1: once again to the audience. While people are concentrating on
- 31:49Speaker 1: problems in the Middle East and Ukraine, all of this
- 31:52Speaker 1: agenda and of course climate change being rammed through for
- 31:57Speaker 1: audience likes what we're doing. UK column News, then police
- 32:02Speaker 1: supporters financially. You can do this by making a donation
- 32:05Speaker 1: or of course taking out a monthly membership, an annual
- 32:09Speaker 1: membership or a lifetime membership, or you can make a
- 32:12Speaker 1: purchase in the shop. And we always highlight that health
- 32:16Speaker 1: products are provided by Clive Decart and we earn a
- 32:18Speaker 1: little bit of commission on those. But we do need
- 32:21Speaker 1: yours financial support to keep running the UK Column news.
- 32:25Speaker 1: But of course what we put out we encourage people
- 32:28Speaker 1: to share, and we share on and we share information
- 32:32Speaker 1: on a number of platforms. If you're a signed up
- 32:35Speaker 1: member then you're able to comment and get involved in
- 32:39Speaker 1: what we're what we're pushing out, but spreading the word
- 32:42Speaker 1: very very important. Now, just like to highlight that my
- 32:46Speaker 1: interview from Tuesday excuse me is now sorry, A big
- 32:54Speaker 1: bond from yesterday I think this one went out is
- 32:57Speaker 1: now up on the UK Column website. I was talking
- 33:01Speaker 1: to Steven Seiser on the subject to Christian Zionism, its origins,
- 33:05Speaker 1: goals and influence. It was a very enjoyable interview, very
- 33:10Speaker 1: very well read man, and he's raising some very interesting
- 33:14Speaker 1: points on the subject Christian Zionism. So if you haven't
- 33:18Speaker 1: seen that, get onto the UK Column website and have
- 33:21Speaker 1: a look. We've also got here an advert for the
- 33:26Speaker 1: Concerned Citizens Advisory Assembly. This is formerly seven Concerned Citizens
- 33:33Speaker 1: of Devon and Cornwall and they've started an initiative to
- 33:36Speaker 1: gain a consensus of concerned citizens in all areas of
- 33:40Speaker 1: the UK and put counsels on notice. They already have
- 33:43Speaker 1: four councilors on notice and they're organizing a series of
- 33:47Speaker 1: zoom calls where they invite members of the public to join.
- 33:50Speaker 1: They've done too so far with success. And in the
- 33:54Speaker 1: zoom they give a presentation about the lack of scrutiny,
- 33:57Speaker 1: risk assessment and due diligence with regards of food security
- 34:01Speaker 1: within net zero climate emergency policies in our town and
- 34:05Speaker 1: city councils and then they ask them simple yes or
- 34:09Speaker 1: no questions in the chat and the aim is to
- 34:12Speaker 1: have multiple zooms with many people to gain numbers to
- 34:16Speaker 1: collate the date of those who are deeply concerned about
- 34:18Speaker 1: food security and cost inefficiency of net zero. The next
- 34:24Speaker 1: zooms are on the twenty fifth twenty seventh of November
- 34:27Speaker 1: at seven pm and Sandy Sandy Adams, who's done a
- 34:31Speaker 1: huge amount of work, is one of the people behind
- 34:34Speaker 1: that Now the other one we've got I think is
- 34:37Speaker 1: yours DEBI Forming and Food Security. Is that correct?
- 34:42Speaker 3: Indeed, this is down to be held in true it's
- 34:45Speaker 3: a farmer's movement Cornwall. So it's Farmers Protests Farming and
- 34:49Speaker 3: Food Security SATSAYE twenty third of November in Truro. All
- 34:54Speaker 3: the details are there and I'm very much hoping to
- 34:56Speaker 3: be down there, So if you happen to be near
- 34:58Speaker 3: Truro or willing to go to make sure I see
- 35:00Speaker 3: you there.
- 35:02Speaker 1: Okay, thank you very much. Now I've got quite a
- 35:04Speaker 1: lot of information in this segment, but I'm going to
- 35:07Speaker 1: go pretty quickly because we want to have time available
- 35:10Speaker 1: in the news for the key thing, which is Cheryld
- 35:14Speaker 1: Granger's report on the MHRA. But I have been taken
- 35:19Speaker 1: over a couple of weeks now by the subject of
- 35:22Speaker 1: child abuse. We've seen reports that the Archbishop of Canterbury
- 35:27Speaker 1: standing down. But this report was sent to me by
- 35:30Speaker 1: several people. Let's have a look at it. It's the
- 35:33Speaker 1: BBC here reporting Children in Need chair resigns over grants
- 35:38Speaker 1: to scandal hit LGBT charity and so in the article
- 35:43Speaker 1: itself it talked about this Rosy Millard objected to a
- 35:48Speaker 1: four hundred and sixty six thousand pound grant being given
- 35:51Speaker 1: by BBC Children in Need to LGBTU Scotland, a charity
- 35:56Speaker 1: which supposedly supports younger and transgender people. And the key
- 36:01Speaker 1: point is a gentleman called James Rennie had been chief
- 36:05Speaker 1: executive of the Scottish organization and he was also an
- 36:10Speaker 1: SMP advisor. But he was jailed in two thousand and
- 36:13Speaker 1: nine after being revealed as a member of a pedophile ring.
- 36:18Speaker 1: And Rennie let's see the detail of this. Rennie was
- 36:22Speaker 1: given a life sentence for sexually assaulting a three month
- 36:26Speaker 1: old child and for conspiring to get access to children
- 36:31Speaker 1: in order to abuse them. And he was a bigger partner.
- 36:34Speaker 1: He was ordered to serve a sentence which was then
- 36:38Speaker 1: subsequently reduced. If we go on here, it's been reported
- 36:44Speaker 1: in this article that another man who contributed to school's
- 36:47Speaker 1: guidance think about that put together by LGBTU Scotland, was
- 36:52Speaker 1: convicted this year of sharing in decent images of children,
- 36:56Speaker 1: including some newborn babies. And in twenty twenty two two
- 37:01Speaker 1: men said they were groomed at the Scottish lgbt Organization
- 37:05Speaker 1: at the time Rennie was chief executive. In response that
- 37:09Speaker 1: the organization suspended a staff member and referred itself to
- 37:14Speaker 1: the police. Now some of the comments by the who
- 37:17Speaker 1: stood down as she criticized BBC Children in Need for
- 37:21Speaker 1: what she said was a lack of due diligence. She
- 37:25Speaker 1: accused the chief executive Simon and Trebus of failing to
- 37:28Speaker 1: respond with the necessary level of seriousness and hesitating to
- 37:33Speaker 1: take action. Remember this is in regard of child protection
- 37:38Speaker 1: child safety issues, and she alleged that he Andrebus eventually
- 37:42Speaker 1: cut funding to the charity, the Scottish charity only because
- 37:46Speaker 1: fear of negative publicity. This is the gentleman in the
- 37:50Speaker 1: limelight at the moment. But extraordinary comments here from the
- 37:55Speaker 1: chief executive of the Scottish lgbt Youth charity. She said
- 38:00Speaker 1: that Millard's resignation letter demonstrates the ideologically driven nature of
- 38:07Speaker 1: her attacks on our organization, so little sympathy for children
- 38:11Speaker 1: there or even babies. She went on to say that
- 38:15Speaker 1: they're pleased to see confirmation that Children in Needs investigations
- 38:19Speaker 1: into the work of LGBTU Scotland found nothing to report,
- 38:24Speaker 1: and she went on time and time again, those with
- 38:26Speaker 1: anti inclusivity motives point to historic allegations in attempts to
- 38:33Speaker 1: destroy our reputation. Allegations have been investigated and cleared by
- 38:37Speaker 1: Police Scotland and proven to have no link to our work.
- 38:41Speaker 1: That'll be the same Scott Clee Scotland that have failed
- 38:45Speaker 1: in so many other child abuse inquiries. Now we want
- 38:49Speaker 1: to go back here to reports from UK column in
- 38:53Speaker 1: twenty fifteen, when we were certainly warning about James Rennie
- 38:57Speaker 1: but also pointing out that he was in with the
- 39:00Speaker 1: political charity Common Purpose. We also pointed out that another
- 39:05Speaker 1: sadistic abuser was in This is Matthew Byrne. He was
- 39:10Speaker 1: also involved with Common Purpose. I believe he had children's
- 39:15Speaker 1: images as well as being responsible for vicious attacks on prostitutes.
- 39:22Speaker 1: But what we were astonished was to see that this man,
- 39:26Speaker 1: with his abuse background and his Common Purpose links, had
- 39:30Speaker 1: at an earlier stage been in direct contact with the
- 39:34Speaker 1: then Prime Minister Cameron, and as we can see in
- 39:38Speaker 1: the photograph, mister Heseltine also present. Now I am sure
- 39:43Speaker 1: at that time the photograph was taken they had no
- 39:46Speaker 1: idea of Matthew Burns's real objectives in life. But what
- 39:52Speaker 1: we did point out was that Common Purpose which was
- 39:56Speaker 1: organizing these training courses including young teenagers, took no overt
- 40:02Speaker 1: action to protect children by instigating some form of vetting
- 40:08Speaker 1: process into the Common Purpose trainers. And at the time
- 40:12Speaker 1: it was Sir David Bell who was the then Common
- 40:15Speaker 1: Purpose Trustee. He of course was getting accolades at the
- 40:19Speaker 1: time for his work with Koram Children's Charity, a lot
- 40:23Speaker 1: of praise. They were honored and thrilled to have him
- 40:25Speaker 1: on board, but he didn't appear to the UK column
- 40:29Speaker 1: at least to be taking the necessary action to protect
- 40:33Speaker 1: children from within the Common Purpose training system. This was
- 40:38Speaker 1: an image we flagged up in twenty fifteen from Koram.
- 40:41Speaker 1: We found this image deeply disturbing. It's the little girl
- 40:45Speaker 1: and the expression on her face and the fact that,
- 40:48Speaker 1: as with NHS video we've just seen, she's been using
- 40:52Speaker 1: to advertise legal information. But we felt so uncomfortable about it.
- 40:58Speaker 1: We asked our audience to respond as to whether they
- 41:01Speaker 1: also thought this was an inappropriate image of a very
- 41:04Speaker 1: young girl. Remember that at the time Common Purpose Charter
- 41:08Speaker 1: was saying that in every society there's an invisible space
- 41:12Speaker 1: between the individual and the state, and that Common Purposes
- 41:16Speaker 1: aim is to fill this space with as many people
- 41:19Speaker 1: as possible, I will say unvetted people, and their ethos
- 41:24Speaker 1: was to create a common educational experience within and across
- 41:28Speaker 1: many countries. And they then claimed, unbelievably that Common Purpose
- 41:33Speaker 1: remained independent and non aligned. This was backed up the
- 41:38Speaker 1: fact that Julia Middleton, the then chief executive, in her
- 41:41Speaker 1: book said, I know that in Downing Street they're always
- 41:45Speaker 1: wondering whether people have sufficient guile to be brought into
- 41:49Speaker 1: a coalition the government is building. Well, that was Common Purpose,
- 41:54Speaker 1: but of course they were also at work inside the BBC.
- 41:57Speaker 1: Here's a UK column freedom of information request which the
- 42:02Speaker 1: response to which produced statistics that the BBC had spent
- 42:06Speaker 1: one hundred and fifty eight thousand over seven years on
- 42:09Speaker 1: Common Purpose training. And on top of that, the BBC
- 42:13Speaker 1: ran a BBC Radio five Live program to defend Common
- 42:18Speaker 1: Purpose against accusations of being a secret society or indeed
- 42:24Speaker 1: involved in a political sense. Now this is the irony
- 42:28Speaker 1: because during that period Chair of Trustees of Common Purpose
- 42:33Speaker 1: was Bishop Tim Stevens. He got very hot under the
- 42:36Speaker 1: collar because people had been criticizing Common Purpose, not least
- 42:41Speaker 1: for their links into censorship of the press. And here
- 42:45Speaker 1: he says British newspapers have in the past link Common
- 42:48Speaker 1: Purpose in the UK to the issues surrounding press regulation.
- 42:53Speaker 1: Says that high profile debate took place, but any link
- 42:58Speaker 1: between Common Purpose and Lord Levison's inquiry was entirely misguided
- 43:03Speaker 1: because Common Purpose has had no involvement whatsoever in the
- 43:07Speaker 1: debate or any campaigns for great regulation of the press.
- 43:12Speaker 1: But he went on to say it was just confusion
- 43:15Speaker 1: because Sir David Bell, Common Purpose Chairman, and Julia Middleton,
- 43:20Speaker 1: the CEO of Common Purpose Charitable Trust, just happened to
- 43:25Speaker 1: both be part of setting up an independent charity called
- 43:28Speaker 1: the Media Standards Trust in two thousand and six, and
- 43:32Speaker 1: of course that rolled into the Levison inquiry and what
- 43:37Speaker 1: we were seeing was blatant attempts to control the press.
- 43:42Speaker 1: Let's remind ourselves that in the last few days the
- 43:45Speaker 1: Archbishop of Canterbury himself has had to resign and the
- 43:50Speaker 1: review found that Justin Wellbe could and should have reported
- 43:54Speaker 1: the abuser John Smith's abuse of boys and young men
- 43:58Speaker 1: to police in twenty thirteen. So a very fast walk
- 44:04Speaker 1: through that particular subject. But my goodness, it's full of
- 44:09Speaker 1: people failing in their duties, turning a blind eye, or
- 44:14Speaker 1: possibly involved in covering deliberate covering up of the abuse
- 44:19Speaker 1: of children. Debbie, let's bring you back on. I watching
- 44:23Speaker 1: the clock because we should have Cheryl joining us any
- 44:28Speaker 1: minute now, so over to you.
- 44:31Speaker 3: Well, thank you, Brian. Well, we certainly will have Cheryl
- 44:34Speaker 3: joining us, and I know she's waiting in the wings ready.
- 44:38Speaker 3: But before I throw across to Cheryl, we have got
- 44:43Speaker 3: some videos that we will show in extra of some
- 44:46Speaker 3: more of the MHRA board meetings. So please, if you're
- 44:50Speaker 3: a member, please stay tuned for extra. It's going to
- 44:53Speaker 3: be super interesting, I can promise you. But before I've
- 44:57Speaker 3: introduced Cheryl, it's all changed at the MHR. We've been
- 45:01Speaker 3: waiting for Graham Cook to step down as interim chair,
- 45:05Speaker 3: and now he can because all of a sudden it's
- 45:08Speaker 3: announced that we have a new chair of the MHRA
- 45:11Speaker 3: board meeting and this is Anthony Hard Hard Hard, I'm sorry.
- 45:17Speaker 3: He is a GP. He's also a professor Primary Care
- 45:21Speaker 3: Oxford until until the end of December. If you go
- 45:25Speaker 3: to the next slide you can see a little bit
- 45:27Speaker 3: more about.
- 45:28Speaker 1: Him and w.
- 45:31Speaker 6: W.
- 45:31Speaker 1: I'm just going to come in because we have got
- 45:33Speaker 1: Cheryl with us now, so I think we'll welcome to
- 45:36Speaker 1: the UK column. Welcome Cheryl. Thank you for giving up
- 45:42Speaker 1: time to join us today and tell us what has
- 45:46Speaker 1: been happening around the MHR. I know that in the
- 45:49Speaker 1: background you've done a fantastic amount of work to tackle
- 45:53Speaker 1: this audience, to tackle the MHRA and to bring to
- 45:59Speaker 1: the audience the real facts about what they have and
- 46:03Speaker 1: have not done. What have you got for us today?
- 46:08Speaker 7: Hello everybody, Thanks for having me on.
- 46:11Speaker 4: Brian.
- 46:13Speaker 7: I can tell you about my first tier appeal that
- 46:18Speaker 7: I've been doing first Tier Tribunal as a result of
- 46:23Speaker 7: a freedom of information I sent off in April twenty three.
- 46:28Speaker 7: I basically through Debbie. I'd heard don June Rain talk
- 46:32Speaker 7: at the or Whales Therapeutics Toxicology Center, and she was
- 46:36Speaker 7: talking about how they were measuring all the reactions to
- 46:40Speaker 7: the vaccines, and she mentioned in particular the Yellow Card
- 46:44Speaker 7: monitor and how this was active surveillance. How excited she
- 46:48Speaker 7: was because within that they had two thousand pregnant women
- 46:51Speaker 7: is what they stated at that time, and that they
- 46:55Speaker 7: would be able to have a denominator for any figures
- 46:58Speaker 7: that they worked out about any of the adverse drug reactions.
- 47:03Speaker 7: So I took a whit of a time because it
- 47:06Speaker 7: took me till Abel to have seen this and write
- 47:08Speaker 7: off my freedom of information. And I basically wrote off
- 47:13Speaker 7: explaining that I'd seen Dune Rain talk about this yellow
- 47:19Speaker 7: card vaccine monitor, and I asked a lot of questions.
- 47:22Speaker 7: There were nine questions I asked about the pregnant, things
- 47:27Speaker 7: like how were the pregnant women monitored, how often did
- 47:31Speaker 7: they import and how long were they being followed for,
- 47:34Speaker 7: when were they vaccinated in which trimester? What was the
- 47:37Speaker 7: percentage of the two thousand I kept referring to two
- 47:40Speaker 7: thousand because that's what she'd said, and that's what I
- 47:42Speaker 7: thought was in their two thousand pregnancies, experiencing things like miscarriages, still,
- 47:46Speaker 7: the spontaneous abortions, et cetera. So I asked nine questions
- 47:50Speaker 7: within my freedom of information, and then on the nineteenth
- 47:56Speaker 7: of July twenty three, I got a reply and the
- 47:59Speaker 7: MHOR refused. They cited Section twenty two, which is to
- 48:05Speaker 7: withhold the information because they intended to have it peer
- 48:07Speaker 7: reviewed and published. But in the meantime they actually sent
- 48:12Speaker 7: me an interim report. So the interim report was in
- 48:17Speaker 7: July twenty twenty one. It was a presentation that they'd
- 48:21Speaker 7: done to the PEAG, which is the Pharmacavigilance Expert Advisory
- 48:27Speaker 7: Group whose remit, by the way, is to assess any
- 48:31Speaker 7: risks that are coming through and then make people aware
- 48:33Speaker 7: of it. So they just sent the interim report. I
- 48:39Speaker 7: asked Professor Fenton to actually analyze it for me, and
- 48:44Speaker 7: he very kindly did, and he was horrified because the
- 48:48Speaker 7: average percentage of adverse drug reactions was about forty one
- 48:53Speaker 7: percent of pregnant women in the review who actually had
- 49:00Speaker 7: at least one adverse drug reaction, and it varied obviously
- 49:04Speaker 7: between the vaccines, with astrozenika be in about sixty percent.
- 49:09Speaker 7: So it was quite telling that this information had not
- 49:14Speaker 7: been released. This is what they were supposed to be
- 49:17Speaker 7: surveying the reactions to the vaccines on and if you
- 49:22Speaker 7: read things that have come forward since, they add the
- 49:25Speaker 7: yellow card details to things that they've seen in the
- 49:29Speaker 7: Yellow Card Vaccine Monitor to come up with the ever
- 49:33Speaker 7: repeated phrase that these vaccines are still safe and effective.
- 49:38Speaker 7: So the MHRA maintained its original position. When I then
- 49:43Speaker 7: asked for an internal review, which is the process you
- 49:45Speaker 7: have to go through and you keep having to wait
- 49:47Speaker 7: twenty days for this to happen. And then in November
- 49:52Speaker 7: twenty twenty three, I complained to the Information Commissioner's Office
- 49:56Speaker 7: because that's what you're supposed to do, and of course
- 49:58Speaker 7: the ICO came back to me and upheld the decision.
- 50:02Speaker 7: So then I actually think I said something on UK
- 50:05Speaker 7: column and then I've got might to that because he
- 50:07Speaker 7: said you've got to appeal. So that's what I did,
- 50:11Speaker 7: and I didn't realize it was such a complex thing
- 50:17Speaker 7: to do. I don't know whether I'll live to regret it,
- 50:19Speaker 7: but at the end of the day, I was determined
- 50:22Speaker 7: to find the information out about pregnancy because of course
- 50:28Speaker 7: that's one of the mhra's major remits. So the MHRA
- 50:34Speaker 7: has developed out of committees that have come along since
- 50:37Speaker 7: the Medicine's at sixty eight, which came into being because
- 50:42Speaker 7: of thelidamide, the thelidamide disaster, and therefore the MHRA, it says,
- 50:49Speaker 7: and they state themselves, we keep watch over medicines and
- 50:52Speaker 7: devices and take necessary action to protect the public promptly
- 50:56Speaker 7: if there's a problem. So they are not supposed to
- 51:02Speaker 7: allow anything to be used in pregnancy unless it is
- 51:05Speaker 7: being proven by clinical trials to actually show that it
- 51:10Speaker 7: is safe. So I then found out that the ICO
- 51:17Speaker 7: we're going to a holder decision, and then I appealed,
- 51:21Speaker 7: So that was the first tlear tribuneal. You have to
- 51:24Speaker 7: fill in a load of forms, which I did, and
- 51:28Speaker 7: it asked you at the bottom whether you want it
- 51:29Speaker 7: to be just a written report that you get a
- 51:32Speaker 7: written conclusion, or whether you wanted a video a tribunal.
- 51:40Speaker 7: And I decided because of the advice I was being given,
- 51:43Speaker 7: to go for it to be a video appearance, obviously
- 51:48Speaker 7: on the internet. So I basically was the only one
- 51:54Speaker 7: of the three of us, because by the twenty ninth
- 51:57Speaker 7: of May, my appeal was just with the ICO. We
- 52:02Speaker 7: then had the ICO asked the MHRA if they wanted
- 52:05Speaker 7: to join in, and they did so in May twenty
- 52:09Speaker 7: four the MHRA became the second respondent, so it's now
- 52:13Speaker 7: me appealing against both of the parties and they decided
- 52:21Speaker 7: that we were going to go to the tribunal on
- 52:26Speaker 7: the nineteenth of September, but they didn't give us enough notice,
- 52:31Speaker 7: which I didn't realize, but the MHRA objected and it
- 52:35Speaker 7: all went through a whole load of emails and then
- 52:38Speaker 7: the judge who I've now met, Judge Wilkins. She decided
- 52:42Speaker 7: that that nineteenth of September could become a direction's hearing,
- 52:47Speaker 7: which panicked me because I ain't got a clue what
- 52:48Speaker 7: that was. But I went along on video and we
- 52:52Speaker 7: talked to each other. There was the barrister, not the
- 52:56Speaker 7: one that's going to be at the tribunal, but the
- 53:01Speaker 7: stand in for the mhrra's barrister was there, the judge
- 53:05Speaker 7: of myself, and it was to try and find a
- 53:07Speaker 7: date when we could all get together and have this hearing.
- 53:13Speaker 7: So it was decided that we'd suggest some dates, which
- 53:17Speaker 7: we did it to gauges to get it confirmed because
- 53:20Speaker 7: it's going to be the third of December, so that's
- 53:23Speaker 7: when the final hearing is going to be. The barrister
- 53:27Speaker 7: at that time told me that the witness that they
- 53:32Speaker 7: wanted to call was Dame during rain, but it doesn't
- 53:36Speaker 7: seem that that's going to happen now as I've got
- 53:39Speaker 7: nearer to the time. So the whole thing was a
- 53:42Speaker 7: bit of a mess because I was supposed to have
- 53:47Speaker 7: everything in. There's been a few changes, but I was
- 53:50Speaker 7: supposed to have everything in, all evidence, all witness statements
- 53:54Speaker 7: by the eighth of November, which is what the other
- 53:57Speaker 7: side had to do as well. Everybody had everything by
- 53:59Speaker 7: the eighth of November. On the sixth of November, I
- 54:02Speaker 7: got an email from the MHR to say we're going
- 54:05Speaker 7: to publish. So on the sixth they actually warned us
- 54:11Speaker 7: that they were going to go to a pre print
- 54:13Speaker 7: server and that would take two to four days. Well
- 54:17Speaker 7: it didn't. It took a week before they notified me
- 54:20Speaker 7: that it was up online and that I could access it,
- 54:23Speaker 7: So it took to the thirteenth of November. They'd wanted
- 54:26Speaker 7: to postpone this presentation of witness statements and evidence until
- 54:32Speaker 7: the fifteenth of November, but I'd actually pushed that out
- 54:34Speaker 7: to the twenty first because I thought I'd need some
- 54:36Speaker 7: time to actually analyze what they'd sent through. So that
- 54:41Speaker 7: brought in a series of emails to keep asking me
- 54:45Speaker 7: to withdraw. So I had four emails at different times
- 54:49Speaker 7: over those few days to ask me to withdraw. First
- 54:52Speaker 7: of all, we're now publishing, so will you withdraw. Then
- 54:56Speaker 7: I obviously went back and said, well, I've got to
- 54:57Speaker 7: see that it actually exists. And then when they told
- 55:01Speaker 7: me that it was being published, or had been published.
- 55:06Speaker 7: They again wanted me to withdraw, and then I said no,
- 55:12Speaker 7: because obviously I wanted to look through it. They asked
- 55:15Speaker 7: me in one email whether I wanted them to point
- 55:17Speaker 7: out to me where the answers were to my questions,
- 55:21Speaker 7: as if I wasn't capable of looking that up from
- 55:23Speaker 7: the detail that they'd sent. And I didn't answer that
- 55:27Speaker 7: because I was a bit offended by that, And they
- 55:30Speaker 7: came back to me and said that eventually would I withdraw,
- 55:35Speaker 7: and I said no. So they then sent me the
- 55:37Speaker 7: list of answers to my questions reference to what they'd
- 55:41Speaker 7: sent through, and they decided to do that without me
- 55:44Speaker 7: saying I wanted it, And so it's been this back
- 55:48Speaker 7: and forth, back and forth, but they constantly wanted me
- 55:51Speaker 7: to withdraw because they thought they provided me with everything
- 55:55Speaker 7: that I'd asked for. So when the information came through,
- 56:00Speaker 7: I obviously needed some help on it. So I went
- 56:02Speaker 7: back to Professor Fenton and he used his colleagues to
- 56:06Speaker 7: very kindly have a look through the information. And so
- 56:09Speaker 7: I've put together a review of that information and the
- 56:15Speaker 7: overriding senses that it hasn't actually answered my question because
- 56:19Speaker 7: of how they've analyzed the data, so we still want
- 56:22Speaker 7: the raw data to be able to analyze it properly
- 56:26Speaker 7: and give answers to the questions that I've asked. Having
- 56:30Speaker 7: said that, they'd already said in a thing that was
- 56:35Speaker 7: called gist of the withheld material is what this sent
- 56:40Speaker 7: through to me at one point, and that came to
- 56:43Speaker 7: the conclusion point forward. The second respondent takes the view
- 56:46Speaker 7: the tribunal can make the decision without looking at the
- 56:48Speaker 7: raw data, so they weren't providing the raw data, It
- 56:51Speaker 7: says the MHRA have provided in its place the spreadsheet
- 56:55Speaker 7: of Yellow Card Vaccine Monitor Data Specification. This is the
- 57:00Speaker 7: sesification provided for the analysis which will inform the publication.
- 57:04Speaker 7: It only contains the data variables which will be analyzed
- 57:07Speaker 7: and does not reflect all the data variables captured within
- 57:10Speaker 7: the YCBM. We didn't really know what that meant, but
- 57:15Speaker 7: it didn't seem to be pro pride in us with
- 57:16Speaker 7: what we wanted.
- 57:18Speaker 1: Cheryl, thank you very much for that. That was your
- 57:22Speaker 1: usual calm, meticulous report. But I want to say to
- 57:26Speaker 1: the audience that although you're delivering this in such a calm,
- 57:30Speaker 1: measured way, the amount of work that's gone into this
- 57:34Speaker 1: is truly phenomenal. You have taken on the MHRA initially
- 57:38Speaker 1: single handedly. You've had some expert help come in alongside you,
- 57:44Speaker 1: which has been really excellent, But that the matter is
- 57:48Speaker 1: that the agency responsible for pharmaceutical safety in UK was
- 57:53Speaker 1: not providing data to the public showing the true risks
- 57:58Speaker 1: as a result of the vaccine policy, particularly in relation
- 58:02Speaker 1: to pregnant women. I'm stunned at that statistic which you've
- 58:06Speaker 1: just released to us, which is problems between forty and
- 58:10Speaker 1: sixty percent with pregnant women. That's truly incredible. But you've
- 58:17Speaker 1: had to work to force this to a tribunal level
- 58:20Speaker 1: in order to get the MHRRA to actually give the
- 58:23Speaker 1: proper data as to what it was doing and what
- 58:26Speaker 1: it's found out with respect to risks to the public tribunal.
- 58:33Speaker 1: You've said on the third of December, this is absolutely
- 58:36Speaker 1: astonishing that I'm going to say, one woman has been
- 58:40Speaker 1: able to work and force this vast public body to
- 58:45Speaker 1: come into a tribunal to explain what they've been doing.
- 58:49Speaker 1: So I don't know if you'd like to respond to that,
- 58:52Speaker 1: but I think your work is utterly incredible.
- 58:56Speaker 7: Well, I suppose I didn't know I was going to
- 58:58Speaker 7: end up here? Did that?
- 59:01Speaker 3: You keep going forward. It's one level after another level
- 59:03Speaker 3: after another level that.
- 59:04Speaker 7: You go through a process. And I mean, I knew
- 59:09Speaker 7: what you know was happening with pregnancy. I knew what
- 59:15Speaker 7: was happening from the fires of adernal document analysis, which
- 59:19Speaker 7: you know from situation room.
- 59:21Speaker 3: I've been involved.
- 59:22Speaker 7: We're trying to done down in a way and put
- 59:25Speaker 7: into simple reports. But they had and I'll read this
- 59:30Speaker 7: because I'll get it wrong, two hundred and seventy four
- 59:33Speaker 7: cases who've become pregnant when they've been told not to.
- 59:36Speaker 7: During the Fiser study, those two hundred and seventy four,
- 59:40Speaker 7: well everybody was told. Every male was told to use
- 59:42Speaker 7: two forms are contraceptive, and females were told not to
- 59:45Speaker 7: get pregnant. But as these things go, two hundred and
- 59:47Speaker 7: seventy four became pregnant. And the outcomes of two hundred
- 59:53Speaker 7: and seventy pregnancies, they've only got thirty two that were followed.
- 59:58Speaker 7: Others have just disappeared. They haven't followed those up. And
- 1:00:01Speaker 7: in those thirty two, we had twenty three spontaneous abortions
- 1:00:06Speaker 7: and five of them had outcome pending as a description
- 1:00:10Speaker 7: and premature and premature birth of neonatal death and spontaneous
- 1:00:14Speaker 7: abortion with interuterine death. There were two each of those,
- 1:00:17Speaker 7: and spontaneous abortion with neonatal death and normal outcome it
- 1:00:21Speaker 7: was one of those. So there were only data of
- 1:00:25Speaker 7: those childred and seventy four cases for twenty nine births
- 1:00:29Speaker 7: and twenty eight other twenty nine died, which might explain
- 1:00:34Speaker 7: why they lost the rest. And obviously, you know, if
- 1:00:37Speaker 7: you know things like that in the information that was
- 1:00:41Speaker 7: given to the MHRA, if they'd read it thoroughly, they
- 1:00:44Speaker 7: would have seen that, and that's a warning to actually
- 1:00:47Speaker 7: not let this be used in pregnancy.
- 1:00:51Speaker 1: Sure, thank you very much. You're joining us for extra
- 1:00:55Speaker 1: in a few minutes and we're going to be discussing
- 1:00:57Speaker 1: this a lot more. But we're going to say to
- 1:01:00Speaker 1: the UK column news audience today, there you have it.
- 1:01:04Speaker 1: Cheryl Granger, with assistance from Versa Fenton and others, has
- 1:01:10Speaker 1: forced the MHRA into a tribunal over data on damage
- 1:01:15Speaker 1: to pregnant women. At least that's just the tip of
- 1:01:18Speaker 1: the iceberg. This is phenomenal work and it's so important
- 1:01:23Speaker 1: that this now gets out to the wider public that
- 1:01:26Speaker 1: this risk exists. And this audience, this authority has been
- 1:01:32Speaker 1: failing in the way it has I think what we're
- 1:01:34Speaker 1: looking at is malfeasance in public office. That's my personal opinion.
- 1:01:39Speaker 1: I don't know whether I'm right, but that's what comes
- 1:01:42Speaker 1: into my head. Debbie just very quickly ask you to comment.
- 1:01:46Speaker 1: We're a little bit over for time on the news,
- 1:01:49Speaker 1: but just to finish off some comment for our news audience, please.
- 1:01:55Speaker 3: Well, I just have to say, you know, I have
- 1:01:59Speaker 3: watched Cheryl for years now working so hard, and you're
- 1:02:05Speaker 3: absolutely right, Brian, this is groundbreaking. And you know, the
- 1:02:09Speaker 3: very fact that the MHRA are continually asking Cheryl to
- 1:02:15Speaker 3: withdraw is testament to the work. And for so long
- 1:02:20Speaker 3: she was completely unsupported and you were completely right when
- 1:02:23Speaker 3: you said it, you know, singlehandedly, single handling. This is
- 1:02:27Speaker 3: what I want to get over to our viewers in
- 1:02:29Speaker 3: that there is so much going on behind the scenes.
- 1:02:32Speaker 3: There are so many amazing people out there doing amazing work,
- 1:02:36Speaker 3: none more so than our angel in human form, Cheryl Granger,
- 1:02:41Speaker 3: because honestly, I have seen her loose sleep, I have
- 1:02:44Speaker 3: seen the bundles of papers, I've seen what she's had
- 1:02:47Speaker 3: to read and what the MHRA have never bothered to read. Seriously,
- 1:02:52Speaker 3: it's completely outstanding and there will be much more about
- 1:02:55Speaker 3: this in Extra and our grateful thanks from all of
- 1:02:59Speaker 3: us from humanity, and for every single pregnant women or
- 1:03:02Speaker 3: every woman who's thinking of becoming pregnant or new dads,
- 1:03:06Speaker 3: please take notice. This is very very serious.
- 1:03:12Speaker 1: Debbie, thank you very much, Cheryl, thank you very much.
- 1:03:15Speaker 1: We must end. There so much to talk about in
- 1:03:19Speaker 1: the news these days, it's very difficult to cover it all,
- 1:03:22Speaker 1: but health issues have got to be absolutely top of
- 1:03:25Speaker 1: the priority. If we're not healthy, we can't fight, we
- 1:03:29Speaker 1: can't look after our families. So health is the key issue.
- 1:03:33Speaker 1: And with pernicious organizations like the MHRA failing in their duty,
- 1:03:38Speaker 1: it's beholden on all of us at the UK Column
- 1:03:42Speaker 1: and our audience out there today to stand up to
- 1:03:45Speaker 1: do something about this. Will end there. If you're a
- 1:03:49Speaker 1: member of UK Column, join us for Extra in a
- 1:03:52Speaker 1: few moments and we'll dive, will dive deeper, as they say,
- 1:03:58Speaker 1: into the subject of the h L Ray and that tribunal.
- 1:04:02Speaker 1: But remember you heard it on UK Column. Thanks for
- 1:04:06Speaker 1: joining us. Bye bye,